Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis

FASEB Journal

Volumn 12, Issue 15, 1998, Pages 1731-1738

  Weidong Richard, J I ^a   Castellino, Francis J ^c   Chang, Yuan ^c   Deford, Melanie E ^c   Gray, Hilary ^a   Villarreal, Xavier ^a   Kondri, Mohammad Eghtedarzadeh ^a   Marti, Daniel N ^b   Llinás, Miguel ^b   Schaller, Johann ^d   Kramer, Robert A ^a   Trail, Pamela A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF NOTRE DAME   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

BCE cells; Fibroblast growth factor; Kringle; Plasminogen

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; PLASMIN; PLASMINOGEN; RECOMBINANT PROTEIN;

ALKYLATION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAPILLARY ENDOTHELIUM; CATTLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; KRINGLE DOMAIN; NONHUMAN; PRIORITY JOURNAL; REDUCTION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALIA; BOS TAURUS;

EID: 0000348061     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.12.15.1731     Document Type: Article

References (46)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
2. Folkman, J. (1995) Clinical applications of research on angiogenesis. New Engl. J. Med. 333, 1757-1763
3. Folkman, J. (1971) Tumor angiogenesis: Therapeutic implications. New Engl. J. Med. 285, 1182-1186
4. Folkman, J., and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931-10934
5. Shing Y., Folkman J., Sullivan, R., Butterfield, C., Murray, J., Klagsbrun, M. (1984) Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 223, 1296-1298
6. Maciag, T., Mehlman, T., Friesel, R., and Schreiber, A. (1984) Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain. Science 225, 932-935
7. Ferrara, N., and Henzel, W. J. (1989) Pituitary follicular cells secrets a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-855
8. Nguyen, M., Watanabe, H., Hudson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. 86, 356-361
9. Dvorak, H. F., Sioussat, T. M., Brown, L. F., Berse, B., Nagy, J. A., Sotrel, A., Manseau, E. J., Van de Water, L., and Senger, D. R. (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 174, 1275-1278
10. Gross, J. L., Herblin, W. F., Dusak, B. A., Czerniak, P., Diamond, M. D., Sun, T., Eidsvoog, K., Dexter, D. L., and Yayon, A. (1993) Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J. Natl. Cancer Inst. 85(2), 121-131
11. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (London) 362, 841-844
12. Lin, P., Polverini, P., Dewhirst, M., Shan, S., Rao, P. S., and Peters, K. (1997) Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie 2 in pathologic vascular growth. J. Clin. Invest. 100, 2072-2078
13. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (London) 367, 576-579
14. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328
15. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285
16. Brooks, P. C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. (1995) Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815-1822
17. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (London) 348, 555-557
18. Ezekowitz, R. A., Mulliken, J. B., and Folkman, J. (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 326, 1456-1463
19. Wiman, B., and Collen, D. (1978) Molecular mechanism of physiological fibrinolysis. Nature (London) 272, 549-550
20. 1H-NMR. Biochemistry 36, 11591-11604
21. Dong, Z., Kumar, R., Yang, X., and Fidler, I. J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810
22. Patterson, B. C., and Sang, Q. A. (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272(46), 28823-28825
23. Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., Volpert, O., Bouck, N., and Soff, G. A. (1997) The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc. Natl Acad. Sci. USA 94, 10868-10872
24. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2, 689-692
25. Lannutti, B. J., Gately, S. T., Quevedo, M. E., Soff, G. A., and Paller, A. S. (1997) Human angiostatin inhibits murine heman-gioendothelioma tumor growth in vivo. Cancer Res. 57, 5277-5280
26. Wu, Z., O'Reilly, M. S., Folkman, J., and Shing, Y. (1997) Suppression of tumor growth with recombinant murine angiostatin. Biochem. Biophys. Res. Commun. 236, 651-654
27. Sim, B. K., O'Reilly, M. S., Liang, H., Fortier, A. H., He, W., Madsen, J. W., Lapcevich, R., and Nacy, C. A. (1997) A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res. 57, 1329-1334
28. Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinás, M., and Folkman, J. (1996) Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467
29. Marti, D., Schaller J., Ochensberger, B., and Rickli, E. E. (1994) Expression, purification and characterization of the recombinant kringle 2 and kringle 3 domains of human plasminogen and analysis of their binding affinity for omega-aminocarboxylic acids. Eur. J. Biochem. 219, 455-462
30. 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains. Biochemistry 35, 2357-2364
31. Nilsen, S. L., DeFord, M. E., Prorok, M., Chibber, B. A. K., Bretthauer, R. K., and Castellino, F. J. (1997) High-level secretion in Pichia pastoris and biochemical characterization of the recombinant kringle 2 domain of tissue-type plasminogen activator. Biotech. Applied Biochem. 25, 63-74
32. Chang, Y., Zajicek, J., and Castellino, F. J. (1997) Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties. Biochemistry 36, 7652-7663
33. Castellino, F. J., Ploplis, V. A., Powell, J. R., and Strickland, D. K. (1981) The existence of independent domain structures in human Lys77-plasminogen. J. Biol. Chem. 256, 4778-4782
34. Folkman, J., Haudenschild, C. C., and Zetter, B. R. (1979) Long-term culture of capillary endothelial cells. Proc. Natl. Acad. Sci. USA 76, 5217-5221
35. Forsgren, M., Raden, B., Israelsson, M., Larsson, K., and Heden, L.-O. (1987) Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. FEBS Lett. 213, 254-260
36. Magnusson, S., Sottrup-Jensen, L., Petersen, T. E., Dudek-Wojciechowska, G., and Claeys, H. (1976) Homologous 'kringle' structures common to plasminogen and prothrombin. Substrate specificity of enzymes activating prothrombin and plasminogen. In: Proteolysis and Physiological Regulation (Ribbons, D. W., and Brew, K., eds) pp. 203-238, New York
37. 1H-NMR study of isolated domains from human plasminogen. Structural homology between kringles 1 and 4. Eur. J. Biochem. 135, 379-391
38. Urano, T., Chibber, B. A. K., and Castellino, F. J. (1987) The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase. Proc. Natl. Acad. Sci. USA 84, 4031-4034
39. Thorsen, S. (1975) Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids. Biochim. Biophys. Acta 393, 55-56
40. Thorsen, S., Clemmensen, J., Sottrup-Jensen, L., and Magnusson, S. (1982) Adsorption to fibrin of native fragments of known primary structure from human plasminogen. Biochim. Biophys. Acta 668, 377-387
41. Lucas, M. A., Fretto, L. J., and McKee, P. A. (1983) The binding of human plasminogen to fibrin and fibrinogen. J. Biol. Chem. 258, 4249-4256
42. Miles, L. A., Dahlberg, C. M., and Plow, E. F. (1988) The cell-binding domains of plasminogen and their function in plasma. J. Biol. Chem. 263, 11928-11934
43. Cao, Y, Chen, A., An, S. S. A., Ji, R. W., Davidson, D., Cao, Y., Llinás, M. (1997) Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928
44. Ji, W. R., Barrientos, L. G., Llinás, M., Gray, H., Villarreal, X., Deford, M. E., Castellino, F. J., Kramer, R. A., and Trail, P. A. (1998) Selective inhibition by Kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem. Biophys. Res. Commun, 247, 414-419
45. Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., Goeddel, D. V., and Collen, D. (1983) Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature (London) 301, 214-221
46. Claeys, H., Sottrup-Jensen, L., Zajdel, M., Petersen, T. E., and Magnusson, S. (1976) Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin. FEBS Lett. 61, 20-24